These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15997843)

  • 1. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.
    Hao X; Cheng G; Yu JE; He Y; An F; Sun J; Cui F
    Pharmazie; 2005 Jun; 60(6):477-8. PubMed ID: 15997843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.
    Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH
    Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats.
    Liu XB; Ye JX; Quan LH; Liu CY; Deng XL; Yang M; Liao YH
    Eur J Pharm Biopharm; 2008 Nov; 70(3):845-52. PubMed ID: 18675905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics.
    Hao X; Cheng G; Sun J; Zou M; Yu J; Zhang S; Cui F
    J Pharm Biomed Anal; 2005 Jun; 38(2):360-3. PubMed ID: 15925232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles.
    Wei Y; Li L; Xi Y; Qian S; Gao Y; Zhang J
    Int J Pharm; 2014 Dec; 476(1-2):142-8. PubMed ID: 25269007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and disposition of scutellarin in rats: a pharmacokinetic explanation for the high exposure of its isomeric metabolite.
    Gao C; Chen X; Zhong D
    Drug Metab Dispos; 2011 Nov; 39(11):2034-44. PubMed ID: 21810967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two major urinary metabolites of scutellarin in rats.
    Qiu F; Xia H; Zhang T; Di X; Qu G; Yao X
    Planta Med; 2007 Apr; 73(4):363-5. PubMed ID: 17354170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mrp2-related efflux of scutellarin in the intestinal absorption in rats.
    Cao F; Zhang H; Guo J; Ping Q
    Pharmazie; 2008 Jan; 63(1):75-80. PubMed ID: 18271309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
    Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
    J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic and tissue distribution study of scutellarin in rats].
    You HS; Dong YL; Xing JF; Zhang CL; Wang MY
    Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1688-92. PubMed ID: 18027669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism profile of scutellarin in urine following oral administration to rats by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry.
    Liu Q; Shi Y; Wang Y; Lu J; Cong W; Luo G; Wang Y
    Talanta; 2009 Nov; 80(1):84-91. PubMed ID: 19782195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
    Huang JM; Weng WY; Huang XB; Ji YH; Chen E
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of scutellarin and its derivant scutellarin ethyl ester in rats].
    Zhu LW; Liu XQ; Feng J; Gao HM; Yi H; Wang ZM; Meng QJ
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(19):3373-7. PubMed ID: 24422411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats.
    Cai Y; Anavy ND; Chow HH
    Drug Metab Dispos; 2002 Nov; 30(11):1246-9. PubMed ID: 12386131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism.
    Wang X; Zhang C; Han N; Luo J; Zhang S; Wang C; Jia Z; Du S
    Drug Deliv; 2021 Dec; 28(1):1664-1672. PubMed ID: 34338567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of pravastatin on transportation of scutellarin in mouse liver and its mechanism].
    Liu JM; Xiong YQ
    Yao Xue Xue Bao; 2011 Mar; 46(3):269-73. PubMed ID: 21626779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction between scutellarin and valsartan in rats.
    Cui MY; Tian CC; Ju AX; Zhang CT; Li QH
    Yao Xue Xue Bao; 2013 Apr; 48(4):541-6. PubMed ID: 23833943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
    Shi S; Wu J; Dai W; Li C; Ge W
    Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and metabolites of scutellarin in normal and model rats].
    Gao HM; Wang ZM; Tian J
    Yao Xue Xue Bao; 2005 Nov; 40(11):1024-7. PubMed ID: 16499088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.